Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Premier Value Fiber Capsules

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. D-030-2013
Class II · Moderate risk

Simply Right Healthcare Fiber Capsules

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. D-029-2013
Class II · Moderate risk

Berkley & Jensen Fiber Capsules

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. D-028-2013
Class II · Moderate risk

Wal-Mucil Plus Calcium Fiber Capsules

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. NDC 0363-0128-24 D-027-2013
Class II · Moderate risk

Wal-Mucil 100% Natural Fiber

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. D-026-2013
Class II · Moderate risk

Up&Up Psyllium Fiber Supplement

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. NDC 11673-059-87 D-025-2013
Class II · Moderate risk

Leader Fiber Capsules

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. NDC 37205-372-78 D-024-2013
Class II · Moderate risk

Equate Fiber Therapy

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. NDC 68163-119-60 D-023-2013
Class II · Moderate risk

Best Choice Health Care

Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.

Terminated Microbial contamination Raritan Pharmaceuticals, Inc. D-021-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1685-2012
Class II · Moderate risk

Atrovent HFA Inhalation Aerosol

Label Mix up; side panel of sticker label applied by Dispensing Solutions Inc. incorrectly indicates product name as Ventolin HFA 90 mcg instead of correctly as Atrovent HFA 12.9 grams Inhalation Aerosol

Terminated Labeling / mix-up Dispensing Solutions, Inc NDC 68258-8952-01 D-1691-2012
Class II · Moderate risk

I-C Drops

Lack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic Preparations and Dispensers, and it is not in compliance with 21 CFR Part 349, Ophthalmic Drug Products for Over-The-Counter Use.

Terminated Sterility / contamination James G. Cole, Inc. D-129-2013
Class II · Moderate risk

Atorvastatin Calcium Tablets

Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.

Terminated Particulate / foreign matter Ranbaxy Inc. NDC 63304-827-90 D-060-2013
Class II · Moderate risk

Nimodipine Capsules 30 mg

Crystallization: Presence of crystals of Nimodipine within the capsule solution.

Terminated Failed specification Caraco Pharmaceutical Laboratories Ltd. NDC 57664-135-64 D-003-2013
Class II · Moderate risk

Doxazosin Tablets

Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.

Terminated Cross-contamination Mylan Pharmaceuticals Inc. D-033-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-24 D-1672-2012
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-344-30 D-180-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-343-30 D-179-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-342-30 D-178-2013
Class II · Moderate risk

Levetiracetam Tablets

Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.

Terminated Particulate / foreign matter Mylan Pharmaceuticals Inc. NDC 0378-5615-05 D-1702-2012
Class II · Moderate risk

Ventolin HFA

Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.

Terminated Other GlaxoSmithKline Inc NDC 0173-0682-20 D-1666-2012

Recalls by year